Home
Conditions
Paramyxoviridae Infections

Clinical trial condition

Paramyxoviridae Infections

Explore clinical trials studying Paramyxoviridae Infections. Study availability and eligibility vary by location and protocol.

354 public trials 28 recruiting studies

Refine in advanced search Browse all conditions

Paramyxoviridae Infections trial results

Completed

Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers

NCT00422292

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +35 more
Locations: Tuscaloosa, Alabama, United States

Tucson, Arizona, United States

Jonesboro, Arkansas, United States

Little Rock, Arkansas, United States

View all 88 locations

View Trial Details

Completed

A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers

NCT00384397

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +35 more
Locations: Montgomery, Alabama, United States

Fayetteville, Arkansas, United States

Jonesboro, Arkansas, United States

Little Rock, Arkansas, United States

View all 39 locations

View Trial Details

Completed

Evaluating the Safety and Immune Response to a Respiratory Syncytial Virus (RSV) Vaccine in Adults, RSV-Seropositive Children, and RSV-Seronegative Infants and Children

NCT01459198

Conditions: Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations: John Hopkins Center for Immunization Research Baltimore, Maryland, United States

View Trial Details

Completed

Safety, Tolerability, and Immunogenicity of 3 Frozen ProQuad Consistency Lots in Healthy Children (V221-012)(COMPLETED)

NCT00985153

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: Not specified

View Trial Details

Completed

A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED)

NCT00092391

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: Not specified

View Trial Details

Completed

Safety, Tolerability and PK Study of AK0529 in Healthy Human

NCT02297594

Conditions: Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations: Q-Pharm Pty Ltd QIMR Berghofer & Royal Brisbane and Women's Hospital Campus Brisbane, Queensland, Australia

View Trial Details

Completed

Innate Immunity and Respiratory Syncytial Virus (RSV) Infection in Children

NCT00593918

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +14 more
Locations: University of Wisconsin-Madison Madison, Wisconsin, United States

View Trial Details

Completed

Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children

NCT02237209

Conditions: Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations: Usc La Nichd Crs Alhambra, California, United States

University of California, UC San Diego CRS La Jolla, California, United States

Univ. of Colorado Denver NICHD CRS Aurora, Colorado, United States

Rush Univ. Cook County Hosp. Chicago NICHD CRS Chicago, Illinois, United States

View Trial Details

Completed

ProQuad™ Versus M-M-R II™ and VARIVAX™ in Healthy Children (V221-009)(COMPLETED)

NCT00975507

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: Not specified

View Trial Details

Completed

MMR and Varicella Vaccine in Premature Infants

NCT00156559

Conditions: Chickenpox, DNA Virus Infections, Female Urogenital Diseases and Pregnancy Complications, +25 more
Locations: University of Rochester Rochester, New York, United States

View Trial Details

Paramyxoviridae Infections

Paramyxoviridae Infections trial results

Related conditions